7Baggers
 Adial Pharmaceuticals' Loss Shrinks As Hopes For AD04 Grow  Finimize Fri, 14 Nov 2025 17:17:51 GMT

Adial Pharmaceuticals, Inc
(NASDAQ:ADIL) 

ADIL stock logo

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment o...

Founded: 2010
Full Time Employees: 3
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends